Analysing Exosome Biology Enables Breakthrough Diagnostic Solutions

Analysing exosomes and their biology can transform disease diagnostics

Illustration of an exosome-based liquid biopsy for liver cancer

What are preventing exosome-based tests being implemented in clinics¹ ?

New exosome technologies are enabling next generation liquid biopsy tests

ExoPheno™ worfklow: from analysing exosome biology to developing nextgen liquid biopsy test

About me



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Pierre Arsène

Pierre Arsène

Founder & CEO @Mursla. Focused on novel exosome-based biomedical applications. Alumna @Cambridge_Uni biophysics, @JPMorgan healthcare IBD & @HECParis